Milan, Italy

Cesare Gennari

This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Pharmacia & Upjohn. Active years: 1998-1999.


% Patents Active = 100.0


Average Co-Inventor Count = 3.4

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 1998-1999

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: **The Innovative Genius of Cesare Gennari**

Introduction

Cesare Gennari is a notable inventor based in Milan, Italy, recognized for his significant contributions to the field of pharmaceuticals. With a remarkable portfolio of two patents, he has played a pivotal role in advancing medical science, particularly through his research on derivatives of aminosulfonic acids and their applications in the preparation of taxol and its derivatives.

Latest Patents

Gennari's latest patents exemplify his innovative spirit:

1. **Derivatives of Aminosulfonic Acids**

2. **Method for the Preparation of Taxol and Its Derivatives**

These patents reflect his commitment to developing effective solutions that can improve therapeutic outcomes in cancer treatment.

Career Highlights

Currently, Cesare Gennari is associated with Pharmacia & Upjohn S.p.a., a leading company in the pharmaceutical industry. His work helps drive the development of new drugs and treatments, demonstrating his invaluable contribution to medicine and health care.

Collaborations

In addition to his individual achievements, Gennari has collaborated with various talented professionals throughout his career. Notable coworkers, including Nicola Mongelli and Ermes Vanotti, have worked alongside him to push the boundaries of scientific research and innovation.

Conclusion

Cesare Gennari's work and patents highlight the critical role inventors play in shaping the future of healthcare. His achievements not only contribute to advancing pharmaceutical science but also inspire future generations of inventors who seek to make a difference in the world.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…